Sanofi SA
PAR:SAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
PAR:SAN
|
FR |
|
Teleperformance SE
PAR:TEP
|
FR |
|
Abb Ltd
OTC:ABBNY
|
CH |
|
Basf Se
OTC:BASFY
|
DE |
|
Crest Nicholson Holdings PLC
LSE:CRST
|
UK |
|
Acasti Pharma Inc
XTSX:ACST
|
CA |
|
Raytheon Technologies Corp
NYSE:RTX
|
US |
|
Valneva SE
PAR:VLA
|
FR |
|
B
|
Bitdeer Technologies Group
NASDAQ:BTDR
|
SG |
|
S
|
South Bow Corp
TSX:SOBO
|
CA |
|
Darktrace PLC
OTC:DRKTF
|
UK |
|
Artisanal Spirits Company PLC
LSE:ART
|
UK |
|
T
|
Tata Steel Ltd
LSE:TTST
|
IN |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
US |
|
St James's Place PLC
LSE:STJ
|
UK |
|
A
|
Avantel Ltd
BSE:532406
|
IN |
|
Heineken NV
F:HNK2
|
NL |
|
G
|
Golden Minerals Co
XBER:7GB
|
US |
|
S
|
Swiss Life Holding AG
XBER:SLW
|
CH |
|
I
|
Infineon Technologies AG
MIL:IFX
|
DE |
|
AB Science SA
PAR:AB
|
FR |
|
A
|
AZZ Inc
XBER:AI7
|
US |
|
Komatsu Ltd
TSE:6301
|
JP |
|
WP Carey Inc
NYSE:WPC
|
US |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
88.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
536.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
204.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
33.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
215.6B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
